Bivalirudin provides increasing benefit with decreasing renal function: A meta-analysis of randomized trials

American Journal of Cardiology

Volumn 92, Issue 8, 2003, Pages 919-923

  Chew, Derek P ^a   Bhatt, Deepak L ^b   Kimball, William ^b   Henry, Timothy D ^b   Berger, Peter ^b   McCullough, Peter A ^b   Feit, Frederick ^b   Bittl, John A ^b   Lincoff, A Michael ^b  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRULOG;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DEATH; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIA; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0141594931     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00970-6     Document Type: Article

References (27)

1. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 39:2002;1113-1119.
2. Korr K.S., Reitman A. Renal implications of percutaneous coronary intervention. Semin Nephrol. 21:2001;36-46.
3. Frilling B., Zahn R., Fraiture B., Mark B., Donges K., Becker T., Siegler K.E., Seidl K., Rustige J., Senges J. Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab. Am J Cardiol. 89:2002;450-452.
4. Jeremias A., Bhatt D.L., Chew D.P., Ziada K.M., Albirini A., Brener S.J., Lincoff A.M., Topol E.J., Ellis S.G. Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. Am J Cardiol. 89:2002;1209-1211.
5. Bittl J.A., Strony J., Brinker J.A., Ahmed W.H., Meckel C.R., Chaitman B.R., Maraganore J., Deutsch E., Adelman B. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. N Engl J Med. 333:1995;764-769.
6. Bittl J.A., Chaitman B.R., Feit F., Kimball W., Topol E.J. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina final report reanalysis of the Bivalirudin Angioplasty Study . Am Heart J. 142:2001;952-959.
7. Kong D.F., Topol E.J., Bittl J.A., White H.D., Theroux P., Hasselblad V., Califf R.M. Clinical outcomes of bivalirudin for ischemic heart disease. Circulation. 100:1999;2049-2053.
8. Lincoff AM. Pilot study of bivalirudin versus heparin during percutaneous coronary intervention with stenting and GP IIb/IIIa blockade: results of the REPLACE-1 trial (abstr). J Am Coll Cardiol 2002;39(suppl A):16A.
9. Lincoff A.M., Kleiman N.S., Kottke-Marchant K., Maierson E.S., Maresh K., Wolski K.E., Topol E.J. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET) . Am Heart J. 143:2002;847-853.
10. White H.D., Chew D.P. Bivalirudin an anticoagulant for acute coronary syndromes and coronary interventions . Expert Opin Pharmacother. 3:2002;777-788.
11. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41.
12. National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) Advisory Board. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002;39(suppl 2):S1-S246.
13. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 7:1986;177-188.
14. McCullough P.A. Cardiorenal risk an important clinical intersection . Rev Cardiovasc Med. 3:2002;71-76.
15. McCullough P.A., Sandberg K.R., Borzak S. Cardiovascular outcomes and renal disease. Ann Intern Med. 136:2002;633-634.
16. McCullough P.A., Soman S.S., Shah S.S., Smith S.T., Marks K.R., Yee J., Borzak S. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 36:2000;679-684.
17. Baigent C., Burbury K., Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 356:2000;147-152.
18. Panichi V., Migliori M., De Pietro S., Taccola D., Bianchi A.M., Norpoth M., Metelli M.R., Giovannini L., Tetta C., Palla R. C reactive protein in patients with chronic renal diseases. Ren Fail. 23:2001;551-562.
19. Shlipak M.G., Heidenreich P.A., Noguchi H., Chertow G.M., Browner W.S., McClellan M.B. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 137:2002;555-562.
20. Beattie J.N., Soman S.S., Sandberg K.R., Yee J., Borzak S., Garg M., McCullough P.A. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis. 37:2001;1191-1200.
21. Sagripanti A., Barsotti G. Bleeding and thrombosis in chronic uremia. Nephron. 75:1997;125-139.
22. Gawaz M.P., Dobos G., Spath M., Schollmeyer P., Gurland H.J., Mujais S.K. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol. 5:1994;36-46.
23. Benigni A., Boccardo P., Galbusera M., Monteagudo J., De Marco L., Remuzzi G., Ruggeri Z.M. Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia. Am J Kidney Dis. 22:1993;668-676.
24. Remuzzi G. Bleeding in renal failure. Lancet. 1:1988;1205-1208.
25. Januzzi J.L. Jr, Snapinn S.M., DiBattiste P.M., Jang I.K., Theroux P. Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial . Circulation. 105:2002;2361-2366.
26. Sagripanti A., Cozza V., Baicchi U., Camici M., Cupisti A., Barsotti G. Increased thrombin generation in patients with chronic renal failure. Int J Clin Lab Res. 27:1997;72-75.
27. Thaler E., Balzar E., Kopsa H., Pinggera W.F. Acquired antithrombin III deficiency in patients with glomerular proteinuria. Haemostasis. 7:1978;257-272.